The effects of a lupin-enriched diet on oxidative stress and factors influencing vascular function in overweight subjects

Antioxidants and Redox Signaling

Volumn 13, Issue 10, 2010, Pages 1517-1524

  Yang, Xingbin ^a,b   Croft, Kevin D ^a   Lee, Ya P ^c   Mori, Trevor A ^a   Puddey, Ian B ^a   Sipsas, Sofia ^d   Barden, Anne ^a   Swinny, Ewald ^e   Hodgson, Jonathan M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SHAANXI NORMAL UNIVERSITY   (China)

^c CURTIN UNIVERSITY   (Australia)

^d DEPARTMENT OF AGRICULTURE AND FOOD WESTERN AUSTRALIA   (Australia)

^e Chemistry Centre Western Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ARGININE; CREATININE; ISOPROSTANE DERIVATIVE; NITRITE; POLYPHENOL; PROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BREAD; CALORIC INTAKE; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FLOUR; HUMAN; LUPIN; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD PRESSURE; BLOOD VESSELS; DIET; F2-ISOPROSTANES; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LUPINUS; MALE; MIDDLE AGED; NITRITES; OVERWEIGHT; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT PREPARATIONS; YOUNG ADULT;

EID: 77957739853     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3133     Document Type: Article

References (43)

1. Appel LJ. The effects of protein intake on blood pressure and cardiovascular disease. Curr Opin Lipidol 14: 55-59, 2003.
2. Barnard JA, Tapsell LC, Davies PS, Brenninger VL, and Storlien LH. Relationship of high energy expenditure and variation in dietary intake with reporting accuracy on 7 day food records and diet histories in a group of healthy adult volunteers. Eur J Clin Nutr 56: 358-367, 2002.
3. Burke V, Hodgson JM, Beilin LJ, Giangiulioi N, Rogers P, and Puddey IB. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension 38: 821-826, 2001.
4. Cernadas MR, Lopez-Farre A, Riesco A, Gallego MJ, Espi-nosa G, Digiuni E, Hernando L, Casado S, and Caramelo C. Renal and systemic effects of amino acids administered separately: Comparison between L-arginine and non-nitric oxide donor amino acids. J Pharmacol Experim Therap 263: 1023-1029, 1992.
5. Cracowski JL, Baguet JP, Ormezzano O, Bessard J, Stanke-Labesque F, Bessard G, and Mallion JM. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension 41: 286-288, 2003.
6. Duranti M and Cerletti P. Amino acid composition of seed proteins of Lupinus albus. J Agric Food Chem 27: 977-978, 1979.
7. Evans A, Cheung P, and Cheetham N. The carbohydrate composition of cotyledons and hulls of cultivars of Lupinus angustifolius from Western Australia. J Sci Food Agric 61: 189-194, 1993.
8. Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, and Tallam L. Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 12: 195-200, 2003.
9. Hodgson JM, and Croft KD. Dietary flavonoids: Effects on endothelial function and blood pressure. J Sci Food Agric 86: 2492-2498, 2006.
10. Hodgson JM, Burke V, Beilin LJ, and Puddey IB. Partial substitution of carbohydrate with protein from lean red meat lowers blood pressure in hypertensive individuals. Am J Clin Nutr 83: 780-787, 2006.
11. Hodgson JM, Croft KD, Mori TA, Burke V, Beilin LJ, and Puddey IB. Regular ingestion of tea does not inhibit lipid peroxidation in vivo. J Nutr 132: 55-58, 2002.
12. Hodgson JM, Proudfoot JM, Croft KD, Puddey IB, Mori TA, and Beilin LJ. Comparison of the effects of black and green tea on in vitro lipoprotein oxidation in human serum. J Sci Food Agric 79: 561-566, 1999.
13. Hodgson JM, Puddey IB, Burke V, Watts GF, and Beilin LJ. Regular ingestion of black tea improves endothelial function in humans. Clin Sci 102: 195-201, 2002. (Pubitemid 34185047)
14. Hodgson JM, Puddey IB, Croft KD, Mori TA, Rivera J, and Beilin LJ. Isoflavonoids do not inhibit in vivo lipid perox-idation in subjects with high-normal blood pressure. Atherosclerosis 145: 167-172, 1999.
15. Hodgson JM. Tea flavonoids and cardiovascular disease. Asia Pacific J Clin Nutr 17: S288-S290, 2008.
16. Kahkonen MP, Hopia AI, Vuorela HJ, Rauha JP, Pihlaja K, Kujala TS, and Heinonen M. Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem 47: 3954-3962, 1999.
17. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, and Benjamin EJ. Framingham Study. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Fra-mingham Study. Arterioscl Thromb Vasc Biol 23: 434-439, 2003.
18. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, and Powell PK. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney: Role of Cyp4F2 and Cyp4A11. J Biol Chem 275: 4118-4126, 2000.
19. Lasztity R, Khalil MM, Haraszi R, Baticz O, and Tomoskozi S. Isolation, functional properties and potential use of protein preparations from lupin. Nahrung 45: 396-398, 2001.
20. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, and Kelm M. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA 98: 12814-12819, 2001.
21. Lee YP, Mori TA, Puddey IB, Sipsas S, Ackland TR, Beilin LJ, and Hodgson JM. The effects of lupin kernel flour-enriched bread on blood pressure: A controlled intervention study. Am J Clin Nutr 89: 766-782, 2009.
22. Lee YP, Mori TA, Sipsas S, Barden A, Puddey IB, Burke V, Hall RS, and Hodgson JM. Lupin-enriched bread increases satiety and reduces energy intake acutely. Am J Clin Nutr 84: 975-980, 2006.
23. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, and Croft KD. Pure dietary flavonoids, quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy human volunteers. Am J Clin Nutr 88: 1018-1025, 2008.
24. Martinez-Villaluenga C, Zielinski H, Frias J, Piskula M, Kozlowska H, and Vidal-Velverde C. Antioxidant capacity and polyphenolic content of high protein lupin products. Food Chem 112: 84-88, 2009.
25. Miyata N, and Roman RJ. Role of 20-hydroxyeicosate-traenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 41: 175-193, 2005.
26. Mori TA, Croft KD, Puddey IB, and Beilin LJ. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 268: 117-125; 1999.
27. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, and van Leeuwen PA. Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418-425, 2001.
28. Oomah BD, Tiger N, Olsen M, and Balasubramanian P. Phenolics and antioxidative activities in narrow-leafed lupins (Lupinus angustifolius L.). Plant Foods Hum Nutr 61: 91-97, 2006.
29. Paine MF, Widmer WW, Hart HL, Pusek SN, Beavers KL, Criss AB, Brown SS, Thomas BF, and Watkins PB. A furanocoumarin-free grapefruit juice establishes furanocoumar-ins as the mediators of the grapefruit juice-felodipine interaction. Am J Clin Nutr 83: 1097-1105, 2006.
30. Pilvi TK, Jauhiainen T, Cheng ZJ, Mervaala EM, Vapaatalo H, and Korpela R. Lupin protein attenuates the development of hypertension and normalises the vascular function of NaCl-loaded Goto-Kakizaki rats. J Physiol Pharmacol 57: 167-176, 2006.
31. Proudfoot JM, Barden AE, Loke WM, Croft KD, Puddey IB, and Mori TA. HDL is the major lipoprotein carrier of plasma F2-isoprostanes. J Lipid Res 50: 716-722, 2009.
32. Quintieri L, Palatini P, Nassi A, Ruzza P, and Floreani M. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. Biochem Pharmacol 75: 1426-1437, 2008.
33. Rodrigo R, Prat H, Passalacqua W, Araya J, and Bachler JP. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci 114: 625-634, 2008.
34. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, and Bachler JP. Relationship between oxidative stress and essential hypertension. Hypertens Res Clin Experim 30: 1159-1167, 2007.
35. Rytlewski K, Olszanecki R, Korbut R, and Zdebski Z. Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest 35: 32-37, 2005.
36. Sanchez M, Lodi F, Vera R, Villar IC, Cogolludo A, Jimenez R, Moreno L, Romero M, Tamargo J, Perez-Vizcaino F, and Duarte J. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta. J Nutr 137: 910-915, 2007.
37. Siani A, Pagano E, Iacone R, Iacoviello L, Scopacasa F, and Strazzullo P. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hy-pertens 13: 547-551, 2000.
38. Singleton VL and Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Viticult 16: 144-158, 1965.
39. Taubert D, Roesen R, and Schomig E. Effect of cocoa and tea intake on blood pressure: A meta-analysis. Arch Intern Med 167: 626-634, 2007.
40. Tsai IJ, Croft KD, Mori TA, Falck JR, Beilin LJ, Puddey IB, and Barden AE. 20-HETE and F2-isoprostanes in the metabolic syndrome: The effect of weight reduction. Free Rad Biol Med 46: 263-270, 2009.
41. Ward NC, Rivera J, Hodgson J, Puddey IB, Beilin LJ, Falck JR, and Croft KD. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 110: 438-443, 2004.
42. Ward NC, Tsai IJ, Barden A, Zilkens R, van Bockxmeer FM, Puddey IB, Hodgson JM, and Croft KD. A single nucleotide polymorphism in the renal CYP4F2 but not CYP4A11 gene is associated with increased urinary 20- hydroxyeicosatetraenoic acid excretion and systolic blood pressure. Hypertension 51: 1393-1398, 2008.
43. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, and Diez J. Oxidative stress in arterial hypertension: Role of NAD(P)H oxidase. Hypertension 38: 1395-1399, 2001.